Press release

Business Wire2 weeks ago

AWS Simplifies Model Customization to Help Customers Build Faster, More Efficient AI Agents

Amazon Bedrock and Amazon SageMaker AI put advanced model customization into the hands of any developer, while reducing costs and…
Read More »
Business Wire2 weeks ago

CyberLink FaceMe eKYC Earns Silver at the 34th Taiwan Excellence Awards

TAIPEI, Taiwan–(BUSINESS WIRE)–CyberLink Corp. (5203.TW), a global leader in digital creative editing software and AI facial recognition, announced that its…
Read More »
Business Wire2 weeks ago

ALK Investors Have Opportunity to Join Alaska Air Group, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES–(BUSINESS WIRE)–$ALK—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…
Read More »
Cision PR Newswire2 weeks ago
0

roommaster Earns 2025 Certificate Of Excellence From HotelTechReport

CLEARWATER, Fla., Dec. 3, 2025 /PRNewswire/ — roommaster, the modern hotel management solution for independent properties, has been awarded the…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

Kibu CEO Daniel Caridi Named to Forbes 30 Under 30 List for Social Impact

STAMFORD, Conn., Dec. 3, 2025 /PRNewswire/ — Kibu, a person-centered platform for disability service providers, announced today that Co-Founder and…
Read More »
Cision PR Newswire2 weeks ago
0

Whittier College Receives Historic Second Gift From Philanthropist MacKenzie Scott

Gift Marks a Resounding Vote of Confidence in Whittier College’s Future WHITTIER, Calif., Dec. 3, 2025 /PRNewswire/ — Whittier College is…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

Korea’s Startups Poised for a Landmark Season as COMEUP 2025 and CES 2026 Draw Near

SEOUL, South Korea, Dec. 3, 2025 /PRNewswire/ — Korea is preparing for a defining season in global innovation, as Seoul…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

U.S. FDA approves expanded indication for Lilly’s Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor

Approval is based on results from the BRUIN CLL-321 trial, the only randomized Phase 3 study in CLL/SLL in which…
Read More »
Business Wire2 weeks ago

Red River Acquires Invictus to Strengthen Cyber and Enterprise Modernization Capabilities

Augments Red River with additional elite talent and advanced capabilities to support critical Department of War and Intelligence Community missions…
Read More »
Business Wire2 weeks ago

Proofpoint Named a Leader in 2025 Gartner® Magic Quadrant™ for Email Security

Proofpoint evaluated as a Leader based on Completeness of Vision and Ability to Execute SUNNYVALE, Calif.–(BUSINESS WIRE)–#EmailSecurity—Proofpoint, Inc., a leading…
Read More »

Previous page Next page